Following Tuesday’s sharp 20% drop, Cantor Fitzgerald analysts labeled the decline in UnitedHealth Group, Inc. (NYSE:UNH) shares as a buying opportunity.
UnitedHealth stock plummeted following a disappointing 2027 Medicare Advantage Advance Notice and a fourth quarter earnings report that met profit expectations, but signaled a rare revenue decline for the coming year.
- UNH stock is moving. See the chart and price action here.
Why Cantor Remains Bullish
Despite the heavy selling, Cantor maintained its Overweight rating and $440 price target on UnitedHealth Group, even as other analysts lowered price targets across the board.
The firm’s bullish conviction is rooted in several key factors:
- Managed Rate Pressures: Cantor attributed over half of Tuesday’s sell-off to the 2027 Medicare Advantage rate notice. The firm sees UnitedHealth mitigating unfavorable rates …